Bms-345541 Medchemexpress

BMS-345541
abx282828-100g 100 µg Ask for price

Human IgG antibody Laboratories manufactures the bms-345541 medchemexpress reagents distributed by Genprice. The Bms-345541 Medchemexpress reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact MedChemExpress Inc.. Other Bms-345541 products are available in stock. Specificity: Bms-345541 Category: Medchemexpress

BMS-345541
10mg
EUR 230

BMS-345541
25mg
EUR 380

BMS-345541
5mg
EUR 170

BMS-345541
5x25mg
EUR 1710

BMS-345541
10mg
EUR 210

BMS-345541
25mg
EUR 290

BMS-345541
2mg
EUR 150

Chemicals information

BMS-345541
T6326-1mg 1mg Ask for price
Description: BMS-345541

BMS-345541
T6326-50mg 50mg Ask for price
Description: BMS-345541

BMS-345541
T6326-5mg 5mg Ask for price
Description: BMS-345541

BMS-593214
HY-114511 Get quote Ask for price
Description: BMS-593214 is an active site-directed factor (F) VIIa inhibitor. BMS-593214 shows antithrombotic and antihaemostatic properties. BMS-593214 is a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of Viia-activated substrate FX. BMS-593214 prevents electroinduced carotid artery thrombosis (AT) and wire induced vena cava thrombosis (VT)[1].

BMS-192364
HY-114865 10 mg
EUR 1948.08
Description: BMS-192364 is targeting the Gα-RGS interaction to produce an inactive Gα-RGS complex. BMS-192364 reduces urinary bladder contraction and exert RGS-agonist properties by increasing the action of GAPs on Gq proteins. BMS-192364 inhibits calcium flux[1][2][3].

BMS-248360
HY-114953 Get quote Ask for price
Description: BMS-248360 is a potent and orally active dual antagonist of both angiotensin II receptor (AT1) and endothelin A (ETA) receptor, with Kis of 10 nM and 1.9 nM for hAT1 and hETA receptor, respectively. BMS-248360 displays hypertensive effects[1].

BMS-911172
HY-115868 10 mg
EUR 2759.78
Description: BMS-911172 is an adaptor associated kinase 1 (AAK1 kinase) inhibitor (IC50 = 35 nM).

BMS-753426
HY-115874 Get quote Ask for price
Description: BMS-753426 is a potent and orally bioavailable antagonist of CCR2.

BMS-795311
HY-19614 Get quote Ask for price
Description: BMS-795311 is a potent and orally bioavailable inhibitor of cholesteryl ester transfer protein (CETP), with IC50s of 4 nM in an enzyme-based scintillation proximity assay (SPA) and 0.22 μM in a human whole plasma assay (hWPA), respectively[1].

BMS-561392
HY-19667 Get quote Ask for price
Description: BMS-561392 is a TNF alpha-converting enzyme (TACE) inhibitor. BMS-561392 is also an ADAM17 blocker. BMS-561392 can be used for research of inflammatory bowel disease[1][2].

BMS-986120
HY-19837 10 mg
EUR 1839.86
Description: BMS-986120 is a first-in-class oral and reversible protease-activated receptor 4 (PAR4) antagonist, with IC50s of 9.5 nM and 2.1 nM in human and monkey blood, respectively. BMS-986120 has potent and selective antiplatelet effects[1][2].

BMS-779788
HY-19919 2mg
EUR 346.33
Description: BMS-779788 is a LXR partial agonist with IC50 values of 68 nM for LXRα and 14 nM for LXRβ.

BMS-986251
HY-136527 1 mg
EUR 11174.42
Description: BMS-986251 is an orally active and selective RORγt inverse agonist with an EC50 of 12 nM for RORγt GAL4. BMS-986251 inhibits IL-17 with an EC50 of 24 nM in human whole blood assay. BMS-986251 demonstrates robust efficacy in mouse acanthosis and Imiquimod-induced (HY-B0180) models (preclinical models of psoriasis)[1].

BMS-833923
HY-13809 100mg
EUR 277.06
Description: BMS-833923 (XL-139) is an orally biocompatible Smoothened (Smo) inhibitor with anti-tumor activity. It can inhibit the binding of BODIPY cyclopamine to SMO in a dose-dependent manner with an IC50 of 21 nM[1].

BMS-585248
HY-13829 Get quote Ask for price
Description: BMS-585248 is a potent, third-generation HIV-1 attachment inhibitor with a promising initial in vitro and in vivo pharmacokinetic profile[1].

BMS-986172
HY-149663 Get quote Ask for price
Description: BMS-986172 is an orally active, highly selective MGAT2 inhibitor with an IC50 of 4.6 nM and 20 nM for hMGAT2 and mMGAT2, respectively. BMS-986172 has a T1/2>120 min in vitro assays. BMS-986172 reduces food intake and body weight. BMS-986172 has the potential for metabolic disorders such as obesity and NASH research[1].

BMS-986339
HY-150787 Get quote Ask for price
Description: BMS-986339 is an orally active, potent FXR agonist. BMS-986339 forms H-bond with His298 and ASN287 residues. BMS-986339 can be used in the research of primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), and nonalcoholic steatohepatitis (NASH), anti-fibrosis[1].